Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Development of monoclonal… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Development of monoclonal antibodies for detection of Antisecretory Factor activity in human plasma.

Artikel i vetenskaplig tidskrift
Författare Ewa Johansson
Ivar Lönnroth
Ingela Jonson
Stefan Lange
Eva Jennische
Publicerad i Journal of immunological methods
Volym 342
Nummer/häfte 1-2
Sidor 64-70
ISSN 1872-7905
Publiceringsår 2009
Publicerad vid Institutionen för biomedicin, avdelningen för medicinsk kemi och cellbiologi
Institutionen för biomedicin, avdelningen för infektionssjukdomar
Sidor 64-70
Språk en
Länkar dx.doi.org/10.1016/j.jim.2008.11.01...
Ämnesord Adult, Animals, Antibodies, Monoclonal, analysis, biosynthesis, Antibody Specificity, Diet, Enzyme-Linked Immunosorbent Assay, methods, Female, Food, Fortified, Humans, Hybridomas, Immunoglobulin Isotypes, analysis, Male, Mice, Mice, Inbred BALB C, Middle Aged, Neuropeptides, blood, isolation & purification, Placenta, Pregnancy, Rats
Ämneskategorier Cell- och molekylärbiologi, Mikrobiologi inom det medicinska området

Sammanfattning

Antisecretory Factor (AF) is expressed in most tissues and can be demonstrated in plasma and other body fluids. Most of the AF in plasma is in an inactive form and activation of AF occurs after exposure to bacterial toxins or after intake of various dietary components. Patients with chronic diseases involving disturbances in inflammatory and secretory processes may benefit from an AF-inducing diet. The aim of the present study was to develop an in vitro assay for the analysis of AF-activity in human plasma. Monoclonal antibodies were raised against a native form of AF prepared from human placenta. Nine clones of the monoclonal antibodies recognizing AF and AF peptides were identified. With the aid of these antibodies, we developed a sensitive ELISA method for direct detection of AF-activity in human plasma. The AF activity in plasma from five healthy volunteers was low, 0.112+/-0.022 (absorbance at 405 nm), before intake of the AF-inducing diet with the SPC-Flakes, and increased significantly (p<0.05) to 0.444+/-0.068 after >or=6 weeks on the diet. A comparison of the plasma-AF values, obtained by the bioassay and the immunogenic assay (indirect ELISA), shows that there is a significant correlation (r=0.85) between the values from the two methods. The results indicate that the ELISA measures AF-activity and has the potential to be an important tool for the analysis of AF-activity in further clinical studies on AF-therapy.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?